Open Access Lectures

Singapore Biodesign Open Access Lecture (OAL) provides a platform for industry experts to share their knowledge and insights on current trends within the Health and MedTech space. 

This interactive series delivers an overview of Health and MedTech Innovation coupled with real-life case studies.


Singapore Biodesign has partnered with EnterpriseSG (ESG) to deliver an exciting Open Access Lecture (OAL) on the latest trends and opportunities in China’s Medtech Industry.

As the population ages and birth rates decrease, many countries, including China, are facing acute health challenges. The Chinese healthcare market is forecast to grow to RMB16 trillion (~SGD3.29 trillion) in 2030 as the country continues developing and improving its healthcare ecosystem (McKinsey, 2018). Notably, China’s thriving medtech industry offers a myriad of opportunities. China has made rapid regulatory reforms since 2015 in order to accelerate the growth of this emerging strategic industry. Such moves have spurred faster development of, and approvals for medical products. From 2015 to 2019, Chinese foreign trade in medical devices grew by nearly 10% each year, outpacing worldwide growth (Deloitte, 2021).

Today, China accounts for around 20% of the global medical device market, and its market share is expected to bolster (Deloitte, 2021). We have invited industry experts with the relevant market knowledge to share their insights: 

  • Ms. Charis Goh, Principal, Head of Equity, Heritas Capital
  • Dr. Lee Phin Peng, Deputy Programme Director, Singapore Biodesign 
  • Ms. Ng Xu Wen, Senior Associate, Innoventures 
  • Mr. Peh Ruey Feng, Head of International R&D and Innovation, Genesis Medtech


Date/Time Lecture Title Flyers
August, 2022 (TBA) OAL-Cl with SingHealth  N.A.
October, 2022 (TBA) OAL-CI with Hospital Cluster  N.A.



Date/Time Lecture Title Flyers
Jul 7, 2021 The Evolution of the Use of Data in Healthcare 
Dr Raghav Sundar, Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore

Dr Su-Peing Ng, VP Global Medical Head @Sanofi Pasteur

Dr Ian Mathews, Deputy Group Chief Technology Officer, NUHS; Consultant, Emergency Medicine, NUHS; Assistant Professor, NUS Yong Loo Lin School of Medicine
Aug 18, 2021 Introduction to Biodesign in Innovation 
Dr Yona Vaisbuch, Founder, Programme Director and Chief Clinical Officer, Biodesign Israel; Otology Neurotolgy Clinical Instructor, Stanford University School of Medicine Otology; Neurotology Surgeon, Rambam Health Care Campus

Mr Biten Kathrani, Head of R&D for Global Myopia, Beauty Contact Lens and Asia Pacific & Japan, Johnson & Johnson Vision Care
Sep 29, 2021 Introduction to China MedTech for Innovators/Startups in Singapore 
Mr Peh Ruey Feng, CEO, G Vascular; SB Founding Faculty and Fellow Mentor

Mr Sean Zhang, Vice President, Business Development, Genesis MedTech

Mr Tan Chuan Seng, Centre Director, A*STAR Partner Centre              
Feb 16, 2022 Digital Transformation in the Healthcare Industry: Experiences with AI
A/Prof Daniel Ting, Director of AI Program, SingHealth

A/Prof Derrick Chan, Senior Consultant of Paediatric Neurology, KK Woman's and Children's Hospital 

Adj Asst/Prof Lim Hong Shen, Head of Health Management, EVYD